Glucose

United States Continuous Glucose Monitoring (CGM) Market 2022: Focus on CGM Vs BGM Market, Reimbursement, Regulation, Initiatives, Growth Drivers, Major Deals, Key Company Profiles, Latest Developments, Demand, Opportunity, and Forecast to 2028

Fri, 21 Oct 2022 15:35:44 +0000

Amid the COVID-19 crisis, the United States Continuous Glucose Monitoring (CGM) was valued at $2,830 Million in 2021 and is expected to grow at a CAGR of 11.5% in the forecast period, to reach $6,000 Million by 2028. The Prominent Factors that are Expected to Contribute to the Growth of the United States Continuous Glucose Monitoring • Rising Incidence of Diabetes • Minimally Invasive in Nature • Less Painful • Real-Time Monitoring • Rapid and Precise Results • New Product Launches • Supportive Government Initiatives • Growing Awareness About Diabetes Preventive Care After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States continuous glucose monitoring (CGM) market are obtained with maximum precision. This new 2022 market report provides a holistic analysis of the entire United States continuous glucose monitoring market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States' continuous glucose monitoring market. The r...

$1,699.00

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 14:45:37 +0000

Summary

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) targeted therapeutics development and features dormant and discontinued projects.

The report helps in identifying and tracking emergi...

$2,500.00

Global Glucose Monitoring Devices Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Glucose Monitoring Devices Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Glucose Monitoring Devices Treatment Devices Market size and future potential? • What is the geographical segmentation of the Glucose Monitoring Devices Treatment Devices Market? • What are the emerging pipeline products available in the Glucose Monitoring Devices Treatment Devices Market? • What are the various products currently under development/pipeline in the Gluco...

$2,000.00

Blood Glucose Meter Market: United States Industry Analysis, Trends, Market Size and Forecasts up to 2026

Mon, 23 May 2022 12:18:53 +0000

Blood Glucose Meter market in the United States is set to surpass US$ 1 Billion threshold by 2026. “Blood Glucose Meter Market: United States Industry Analysis, Trends, Market Size and Forecasts up to 2026” presents an in-depth assessment of the United States blood glucose meter market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the United States blood glucose meter market. The report includes historical data from 2013 to 2018 and forecasts until 2026. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026.The report provides clear insight into current and future developments of the United States blood glucose meter market. The report provides a decisive view on the US blood glucose meter users and market size. The report also provides an all-round analysis of overall number of patients with diabetes and insulin u...

$1,290.00

United States Continuous Glucose Monitoring (CGM) Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2027

Mon, 23 May 2022 12:18:53 +0000

The United States Continuous Glucose Monitoring (CGM) market size is expected to surpass USD 5 billion by 2027. “United States Continuous Glucose Monitoring (CGM) Market Report” is based on an inclusive study of the entire United States Continuous Glucose Monitoring (CGM) market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States Continuous Glucose Monitoring (CGM) market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2021 – 2027. The report delivers a clear understanding of the up-to-date and future growths of the United States Continuous Glucose Monitoring (CGM) market. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for Continuous Glucose Monitoring (CGM), and an illustrative forecast for 2027. The report also provides an all-around analysis of the overall number of patients with diabetes and insulin users in the United State...

$1,599.00

Global Instant Blood Glucose Meter Market Research Report 2022-2026

Wed, 13 Apr 2022 14:34:41 +0000

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Instant Blood Glucose Meter Report by Material, Application, and Geography – Global Forecast to 2026 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Instant Blood Glucose Meter market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026. The report firstly introduced the Instant Blood Glucose Meter basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth ra...

$3,200.00

Blood Glucose monitoring systems Market Insights, Competitive Landscape and Market Forecast–2025

Fri, 05 Feb 2021 15:36:57 +0000

DelveInsight’s ‘Blood Glucose monitoring systems-Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Blood Glucose monitoring systems and the historical and forecasted Blood Glucose monitoring systems market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. The Blood Glucose monitoring systems market report provides an overview of Blood Glucose monitoring systems, reasons to get Blood Glucose monitoring systems as well as its advantages and limitations. Additionally, the report provides insight on the Blood Glucose monitoring systems market share of the individual Blood Glucose monitoring systems devices, current and forecasted Blood Glucose monitoring systems market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market. Blood Glucose monitoring systems Overview The quantity of sugar present in the blood sample is de...

$4,750.00

Global Glucose Meter Test Paper Market Research Report 2019-2023

Mon, 11 Nov 2019 14:17:56 +0000

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Glucose Meter Test Paper Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Glucose Meter Test Paper market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Glucose Meter Test Paper basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and fo...

$2,850.00

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2019

Wed, 27 Mar 2019 16:02:56 +0000

Summary

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 13 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H1 2019, outlays comprehensive information on the Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Glucose-dependent insulinotropic polypeptide receptor (GIPR) is a transmembrane protein in humans which is encoded by the GIPR gene. GIPR is expressed on pancreatic beta-cells which lead to activation and release of insulin. The transcription of this protein is positively controlled by glucose molecule...

$3,500.00

Survey of China’s Glucose Industry in 2016

Wed, 14 Dec 2016 12:12:43 +0000

1.INTRODUCTION In this report, ASKCI analyzes the investment opportunities of China’s glucose industry. It will provide you with a comprehensive understanding of this industry from the following aspects: market size, status in the world, product structure, company analysis of major players, etc., as well as make scientific prediction on the future development glucose industry. 1)The Aim of this report -To provide readers with comprehensive & in-depth understanding of Chinese glucose industry; -To understand position of China’s glucose in the world; -Get more information of the major glucose companies; -To predict what future of China’s glucose industry will be; -To find out the key strengths and weakness of China’s glucose companies, and the threats and opportunities they face; -To reveal opportunities in Chinese glucose industry. 2)Benefit from the report -Obtain latest info of glucose industry, such as market size, product structure, status in the world. key hotspots and so on; -Get latest information of major glucose companies in China; -Evaluate the status of China’...

$6,000.00

US Market Report for Blood Glucose Meters 2017 - MedCore

Wed, 16 Nov 2016 10:08:44 +0000

The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by individuals who manage their diabetes outside of the professional setting and monitor their blood glucose levels as a part of daily care. As the prevalence of diabetes in the U.S. increases, it is expected that the personal segment will continue to account for the majority of the total blood glucose meter market. Professional meters are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, a...

$4,495.00

US Market Report for Blood Glucose Test Strips 2017 - MedCore

Wed, 16 Nov 2016 10:08:44 +0000

The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of blood glucose (SMBG) on a daily basis. The personal test strip market is further segmented by insurance type and comprises the Medicare/Medicaid, managed care and cash sub-segments. CMS competitive bidding had a significant impact on the personal test strip market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Professional test strips are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or othe...

$5,495.00

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

Wed, 16 Nov 2016 10:08:44 +0000

The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement, technological innovation and increased uptake of personal CGM among type 1 diabetics and insulin-dependent type 2 diabetics. Professional CGM is typically used in retrospective sessions initiated by physicians, during which a patient wears a CGM sensor for several days to a week, but is ‘blinded’ to the real-time CGM data and must adhere to frequent self-monitoring of blood glucose (SMBG) using traditional blood glucose meters. Additionally, the patient must maintain a record of their daily dietary intake and activity during the time that the sensor is worn. At the end of the session, the patient returns to their physician to remove the sensor and retrospectively analyze the glucose data that was collected. The ‘blinded’ aspect of professional CGM allows ph...

$5,495.00